The Use of Budesonide in the Treatment of Autoimmune Hepatitis in Canada
BACKGROUND: Autoimmune hepatitis (AIH) is a chronic inflammatory disease that is successfully treated with prednisone and/or azathioprine immunosuppressive therapy in 70% to 80% of patients. The remaining patients are intolerant or refractory to these standard medications. Budesonide, a synthetic gl...
Saved in:
| Main Authors: | Iman Zandieh, Darin Krygier, Victor Wong, John Howard, Lawrence Worobetz, Gerald Minuk, Helga Witt-Sullivan, Eric M Yoshida |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2008-01-01
|
| Series: | Canadian Journal of Gastroenterology |
| Online Access: | http://dx.doi.org/10.1155/2008/509459 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Clozapine-Induced Fatal Fulminant Hepatic Failure: A Case Report
by: Albert Chang, et al.
Published: (2009-01-01) -
Budesonide in treatment of alcohol-induced severe hepatitis: results of randomized trial
by: I. I. Komkova, et al.
Published: (2013-09-01) -
Treatment of Chronic Hepatitis C in a Canadian Aboriginal Population: Results from the Prairie Study
by: Gerald Yosel Minuk, et al.
Published: (2013-01-01) -
Budesonide for the Treatment of Inflammatory Bowel Disease
by: Gordon R Greenberg
Published: (1994-01-01) -
Budesonide Enemas for Topical Therapy of Ulcerative Colitis
by: P Rutgeerts
Published: (1990-01-01)